Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis.

Alexander ES, Martin LJ, Collins MH, Kottyan LC, Sucharew H, He H, Mukkada VA, Succop PA, Abonia JP, Foote H, Eby MD, Grotjan TM, Greenler AJ, Dellon ES, Demain JG, Furuta GT, Gurian LE, Harley JB, Hopp RJ, Kagalwalla A, Kaul A, Nadeau KC, Noel RJ, Putnam PE, von Tiehl KF, Rothenberg ME.

J Allergy Clin Immunol. 2014 Nov;134(5):1084-1092.e1. doi: 10.1016/j.jaci.2014.07.021. Epub 2014 Sep 22.

2.

High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders.

Abonia JP, Wen T, Stucke EM, Grotjan T, Griffith MS, Kemme KA, Collins MH, Putnam PE, Franciosi JP, von Tiehl KF, Tinkle BT, Marsolo KA, Martin LJ, Ware SM, Rothenberg ME.

J Allergy Clin Immunol. 2013 Aug;132(2):378-86. doi: 10.1016/j.jaci.2013.02.030. Epub 2013 Apr 19.

3.

PedsQL eosinophilic esophagitis module: feasibility, reliability, and validity.

Franciosi JP, Hommel KA, Bendo CB, King EC, Collins MH, Eby MD, Marsolo K, Abonia JP, von Tiehl KF, Putnam PE, Greenler AJ, Greenberg AB, Bryson RA, Davis CM, Olive AP, Gupta SK, Erwin EA, Klinnert MD, Spergel JM, Denham JM, Furuta GT, Rothenberg ME, Varni JW.

J Pediatr Gastroenterol Nutr. 2013 Jul;57(1):57-66. doi: 10.1097/MPG.0b013e31828f1fd2.

4.

Toll-like receptor 7 is required for effective adaptive immune responses that prevent persistent virus infection.

Walsh KB, Teijaro JR, Zuniga EI, Welch MJ, Fremgen DM, Blackburn SD, von Tiehl KF, Wherry EJ, Flavell RA, Oldstone MB.

Cell Host Microbe. 2012 Jun 14;11(6):643-53. doi: 10.1016/j.chom.2012.04.016.

5.

Clopidogrel desensitization after drug-eluting stent placement.

von Tiehl KF, Price MJ, Valencia R, Ludington KJ, Teirstein PS, Simon RA.

J Am Coll Cardiol. 2007 Nov 20;50(21):2039-43. Epub 2007 Nov 5.

6.

The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model.

Ferrario A, Chantrain CF, von Tiehl K, Buckley S, Rucker N, Shalinsky DR, Shimada H, DeClerck YA, Gomer CJ.

Cancer Res. 2004 Apr 1;64(7):2328-32.

7.

Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response.

Ferrario A, Von Tiehl K, Wong S, Luna M, Gomer CJ.

Cancer Res. 2002 Jul 15;62(14):3956-61.

8.

Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.

Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ.

Cancer Res. 2000 Aug 1;60(15):4066-9.

Supplemental Content

Loading ...
Support Center